11/29/2018 / By Ellaine Castillo
A series of studies known as the China Stroke Primary Prevention Trial revealed that folate supplementation causes significant improvements in the mortality of hypertensive patients. This finding, published in the Journal of Hypertension, was based on the results of separate clinical trials.
Overall, the results of these studies prove folate supplementation significantly reduces the incidence of stroke and the mortality risk of hypertensive patients with renal dysfunction in the form of excessive protein excretion in the urine.
Read the full text of the study at this link.
For more articles about how supplements can improve health, visit SupplementsReport.com
Journal Reference:
Kahan T, Spaak J. POTENTIAL OF FOLATE SUPPLEMENTATION TO REDUCE MORTALITY IN HYPERTENSIVE PATIENTS. Journal of Hypertension. June 2017;35(6). DOI:10.1097/hjh.0000000000001352
Tagged Under:
folate, high blood pressure, hypertension, life expectancy, longevity, mortality, nutrients, proteinuria, renal dysfunction, supplements, Vitamin B, vitamin B9
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 NUTRIENTS NEWS